Home/Filings/4/0001415889-22-009970
4//SEC Filing

MYERS ROBERT L 4

Accession 0001415889-22-009970

CIK 0001446159other

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 3:06 PM ET

Size

9.1 KB

Accession

0001415889-22-009970

Insider Transaction Report

Form 4
Period: 2022-09-23
MYERS ROBERT L
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2022-09-23$0.39/sh10,199$4,02862,470 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-09-2333,33333,333 total
    Common Stock (33,333 underlying)
  • Exercise/Conversion

    Common Stock

    2022-09-23+33,33372,669 total
Footnotes (3)
  • [F1]On September 23, 2020, the reporting person was granted 100,000 restricted stock units, vesting in three annual installments on each of September 23, 2021, September 23, 2022 and September 23, 2023.
  • [F2]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
  • [F3]10,199 shares of common stock forfeited to Company on September 23, 2022 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.

Issuer

Predictive Oncology Inc.

CIK 0001446159

Entity typeother

Related Parties

1
  • filerCIK 0001553600

Filing Metadata

Form type
4
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 3:06 PM ET
Size
9.1 KB